Indications and uses
for temporary relief of: occasional minor irritation, pain, sore mouth, and sore throat pain associated with canker sores minor discomfort and protection of irritated areas in sore mouth and sore throat
for temporary relief of: occasional minor irritation, pain, sore mouth, and sore throat pain associated with canker sores minor discomfort and protection of irritated areas in sore mouth and sore throat
adults and children 4 years of age and older: Spray 4 times into throat or affected area. Gargle, swish around or allow to remain in place at least 1 minute and then spit out. Repeat up to 4 times daily or as directed by a dentist or doctor. Children 4 to under 12 years of age should be supervised in the use of this product. children under 4 years of age: do not use
store at room temperature 20-25°C (68-77°F) do not freeze
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Dyclonine Hydrochloride 0.1% | Oral pain reliever |
| Glycerin 33% | Oral demulcent |
for temporary relief of:
If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea or vomiting, consult a doctor promptly.
If pregnant or breast-feeding,ask a health professional before use.
Keep out of the reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
Do not exceed recommended dosage.
When using this producttry to avoid swallowing spray.
cetylpyridinium chloride, D&C red #33, deionized water, FD&C yellow #6, flavor, menthol, phosphoric acid, poloxamer 338, potassium sorbate, sodium phosphate dibasic, sorbitol
1-888-963-3382
You may also report side effects to this phone number.
Dist. by: Reckitt Benckiser
Parsippany, NJ 07054-0224
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63824-781-74 | 2023-09-27 | C162847 | 48780-1 | d6a99b39-eaf7-a426-e053-dadaa90af4c2 | Cēpacol ® SORE THROAT SPRAY |
| 63824-781-74 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-eaf7-a426-e053-dadaa90af4c2 | Cēpacol ® SORE THROAT SPRAY |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Dyclonine Hydrochloride | ACTIVE INGREDIENT | ZEC193879Q | 1 | |
| Glycerin | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Dyclonine | ACTIVE MOIETY | 078A24Q30O | 1 | |
| Glycerin | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| cetylpyridinium chloride | INACTIVE INGREDIENT | D9OM4SK49P | 1 | |
| D&C red No. 33 | INACTIVE INGREDIENT | 9DBA0SBB0L | 1 | |
| FD&C yellow No. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 1 | |
| menthol | INACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| phosphoric acid | INACTIVE INGREDIENT | E4GA8884NN | 1 | |
| poloxamer 338 | INACTIVE INGREDIENT | F75JV2T505 | 1 | |
| potassium sorbate | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| sodium phosphate, dibasic | INACTIVE INGREDIENT | GR686LBA74 | 1 | |
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63824-781 | 63824-781-74 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CETYLPYRIDINIUM CHLORIDE | D9OM4SK49P | IACT |
| D&C RED NO. 33 | 9DBA0SBB0L | IACT |
| WATER | 059QF0KO0R | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| MENTHOL, UNSPECIFIED FORM | L7T10EIP3A | IACT |
| PHOSPHORIC ACID | E4GA8884NN | IACT |
| POLOXAMER 338 | F75JV2T505 | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM | GR686LBA74 | IACT |
| SORBITOL | 506T60A25R | IACT |
| DYCLONINE HYDROCHLORIDE | ZEC193879Q | ACTIB |
| GLYCERIN | PDC6A3C0OX | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| sorbitol | SORBITOL | 506T60A25R | SOLUTION / OPHTHALMIC | 6 mg | ||
| sorbitol | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| menthol | MENTHOL | L7T10EIP3A | CREAM / TOPICAL | 0.1 %w/w | ||
| cetylpyridinium chloride | CETYLPYRIDINIUM CHLORIDE | D9OM4SK49P | SOLUTION / OPHTHALMIC | 0.01 %w/w | ||
| D&C red No. 33 | D&C RED NO. 33 | 9DBA0SBB0L | CAPSULE, LIQUID FILLED / ORAL | 0.01 mg | ||
| menthol | MENTHOL | L7T10EIP3A | LOTION / TOPICAL | 0.05 %w/w | ||
| menthol | MENTHOL | L7T10EIP3A | CONCENTRATE / ORAL | 0.05 mg/5ml | ||
| menthol | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | SOLUTION / OPHTHALMIC | ADJ PH | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| sorbitol | SORBITOL | 506T60A25R | SOLUTION/ DROPS / OPHTHALMIC | 0.25 %w/v | ||
| sorbitol | SORBITOL | 506T60A25R | TABLET, EXTENDED RELEASE / ORAL | 428 mg | ||
| menthol | MENTHOL | L7T10EIP3A | DROPS / OPHTHALMIC | NA | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | LOTION, AUGMENTED / TOPICAL | 1 mg | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| sodium phosphate, dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CONCENTRATE / ORAL | 17 mg/5ml | ||
| sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| D&C red No. 33 | D&C RED NO. 33 | 9DBA0SBB0L | SUSPENSION / ORAL | 0.13 mg/5ml | ||
| menthol | MENTHOL | L7T10EIP3A | DROPS / NASAL | 40.32 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | SOLUTION / ORAL | 19 mg | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, EXTENDED RELEASE / ORAL | 8 mg | ||
| sorbitol | SORBITOL | 506T60A25R | EMULSION / TOPICAL | 7 %w/w | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, FILM COATED / ORAL | 1 mg | ||
| sorbitol | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE / ORAL | 7 mg | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | FILM / SUBLINGUAL | 0.03 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / BUCCAL | 5110 mg | ||
| D&C red No. 33 | D&C RED NO. 33 | 9DBA0SBB0L | SOLUTION / DENTAL | NA | ||
| sorbitol | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET / ORAL | 60.02 mg | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE, DELAYED RELEASE / ORAL | 0.02 mg | ||
| sorbitol | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | SPONGE / TOPICAL | ADJ PH | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SOAP / TOPICAL | 0.2 %w/w | ||
| sorbitol | SORBITOL | 506T60A25R | TABLET, FILM COATED / ORAL | 5 mg | ||
| D&C red No. 33 | D&C RED NO. 33 | 9DBA0SBB0L | CAPSULE / ORAL | 1 mg | ||
| sorbitol | SORBITOL | 506T60A25R | TABLET / ORAL | 337.28 mg | ||
| menthol | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| cetylpyridinium chloride | CETYLPYRIDINIUM CHLORIDE | D9OM4SK49P | AEROSOL, METERED / RESPIRATORY (INHALATION) | NA | ||
| cetylpyridinium chloride | CETYLPYRIDINIUM CHLORIDE | D9OM4SK49P | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | NA | ||
| sorbitol | SORBITOL | 506T60A25R | PASTE, DENTIFRICE / DENTAL | 14 %w/w | ||
| sorbitol | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SYRUP / ORAL | 4 mg/5ml | ||
| menthol | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| sodium phosphate, dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / SUBCUTANEOUS | 14 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| FD&C yellow No. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SOLUTION / ORAL | 75.3 mg/15ml | ||
| sorbitol | SORBITOL | 506T60A25R | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | TABLET, EXTENDED RELEASE / ORAL | 0.19 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 6 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | AEROSOL, FOAM / VAGINAL | NA | ||
| menthol | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | CREAM / VAGINAL | 0.56 %w/w | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | TABLET / ORAL | 0.04 mg | ||
| D&C red No. 33 | D&C RED NO. 33 | 9DBA0SBB0L | SHAMPOO / TOPICAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0650e5e8-122a-6c92-e063-6394a90ac9c0 | af621c32-ec5d-4f5a-ae19-6ff260675ac8 | 2023-09-27 | Warnings | 0650e5e8-122a-6c92-e063-6394a90ac9c0 af621c32-ec5d-4f5a-ae19-6ff260675ac8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.